2022
DOI: 10.1016/j.phoj.2022.10.184
|View full text |Cite
|
Sign up to set email alerts
|

Early experience with blinatumomab in B-cell precursor (BCP) acute lymphoblastic leukaemia (ALL) at the Tata Medical Center (TMC), Kolkata

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles